Vimarsana
Biggest News Aggregation in the World

Nasal Administration News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasal Administration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasal Administration Today - Breaking & Trending Today

CSPAN Oversight Hearing On Drug Control Policy December 6, 2015 - Vimarsana News

CSPAN Oversight Hearing On Drug Control Policy December 6, 2015

Record as secretary of state. What does she want to run on . What is the platform . She is going to be the first woman president. Ask for your support because i am a woman, though i am proud to be one. But i will force Hillary Clinton to fight on ground where she will have to talk about the reality that every one of her policies are bad for women as well as men. Fight on the to ground of her track record and if she faces me, we will win. [applause] i think that is a perfect conclusion to our day. Happy hanukkah ladies and gentlemen. Happy 30th anniversary. On the roadkes you to the white house...

Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update - Roche Holding (OTC:RHHBY), Sanofi (NASDAQ:SNY) - Vimarsana News

Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update - Roche Holding (OTC:RHHBY), Sanofi (NASDAQ:SNY)

Tiziana Life Sciences Ltd. (NASDAQ: TLSA) recently announced the Company has initiated site selection for its lead intranasal anti-CD3 monoclonal antibody drug c

Study evaluating intranasal anti-CD3 for treatment of Alzheimer's disease published in the PNAS journal - Vimarsana News

Study evaluating intranasal anti-CD3 for treatment of Alzheimer's disease published in the PNAS journal

Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced acceptance of a publication, “Nasal Administration of anti-CD3 monoclonal antibody (mAb) ameliorates disease in a mouse model of Alzheimer’s disease”, in the preeminent journal, Proceedings of the National Academy of Sciences (PNAS), that supports foralumab’s mechanism as a potential treatment for Alzheimer’s disease (AD), a difficult-to-treat neuroinflammatory disease.

Study Validating MoA of Intranasal Foralumab in Alzheimer's Disease Published in the Prestigious Journal PNAS, Following FDA IND Clearance Seite 1 - Vimarsana News

Study Validating MoA of Intranasal Foralumab in Alzheimer's Disease Published in the Prestigious Journal PNAS, Following FDA IND Clearance Seite 1

06.09.2023 - The authors conclude that “nasal anti-CD3 has the potential to be a non-toxic novel immunotherapeutic approach for the treatment of Alzheimer’s disease (AD)”FDA has cleared the IND for intranasal foralumab, a fully human anti-CD3 monoclonal ... Seite 1

Ancient Purification Rituals: Exploring Cleansing and Spiritual Renewal - Vimarsana News

Ancient Purification Rituals: Exploring Cleansing and Spiritual Renewal

From the Maya's sweat lodge ceremony to Japan's Misogi ritual, the wisdom of body, mind and soul renewal have left a lasting gift in our modern quest of holistic well-being.